home.social

#obesity — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #obesity, aggregated by home.social.

fetched live
  1. GLP-1 meds prompt rethink of obesity and eating disorder care

    Obesity and eating disorders have traditionally been treated as separate areas of healthcare – but the rapid rise…
    #NewsBeep #News #Health #appetite #AU #Australia #EatingDisorder #Healthcare #Obesity
    newsbeep.com/au/869105/

  2. GLP-1 meds prompt rethink of obesity and eating disorder care

    Obesity and eating disorders have traditionally been treated as separate areas of healthcare – but the rapid rise…
    #NewsBeep #News #Health #appetite #AU #Australia #EatingDisorder #Healthcare #Obesity
    newsbeep.com/au/869105/

  3. Obesity Action Coalition Calls on Starbucks to Reverse Decision to End GLP-1 Coverage for Obesity

    TAMPA, Fla., Aug. 21, 2026 /PRNewswire/ — The Obesity Action Coalition (OAC) is calling on Starbucks to reverse…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #EmployeeBenefits #Health #healthplancoverage #OAC #Obesity #reporteddecision #Starbucks
    newsbeep.com/us/825518/

  4. Obesity Action Coalition Calls on Starbucks to Reverse Decision to End GLP-1 Coverage for Obesity

    TAMPA, Fla., Aug. 21, 2026 /PRNewswire/ — The Obesity Action Coalition (OAC) is calling on Starbucks to reverse…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #EmployeeBenefits #Health #healthplancoverage #OAC #Obesity #reporteddecision #Starbucks
    newsbeep.com/us/825518/

  5. US adult obesity rates drop to 37.0% from a 2022 peak of 39.9%, marking the first decline in decades

    New data indicates a potential turning point in U.S. adult obesity prevalence, with rates dropping from a 2022 peak.

    newsnews.ai/article/us-adult-o

  6. Amylyx endocrine drug succeeds in key study for low blood sugar

    Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
    #NewsBeep #News #Medication #Biotechnology #drugdevelopment #Health #Obesity #research #STAT+ #UK #UnitedKingdom
    newsbeep.com/uk/746759/

  7. 📊 In the NEJM STEP 9 trial, 407 adults with obesity and knee osteoarthritis receiving once-weekly semaglutide lost 13.7% of body weight vs. 3.2% with placebo, with greater reductions in knee pain and improved physical function over 68 weeks. GI events led to discontinuation in 6.7%. #Obesity #Osteoarthritis nejm.org/doi/abs/10.1056/NEJMo

  8. 📊 In the NEJM STEP 9 trial, 407 adults with obesity and knee osteoarthritis receiving once-weekly semaglutide lost 13.7% of body weight vs. 3.2% with placebo, with greater reductions in knee pain and improved physical function over 68 weeks. GI events led to discontinuation in 6.7%. #Obesity #Osteoarthritis nejm.org/doi/abs/10.1056/NEJMo

  9. 📊 In the NEJM STEP 9 trial, 407 adults with obesity and knee osteoarthritis receiving once-weekly semaglutide lost 13.7% of body weight vs. 3.2% with placebo, with greater reductions in knee pain and improved physical function over 68 weeks. GI events led to discontinuation in 6.7%. #Obesity #Osteoarthritis nejm.org/doi/abs/10.1056/NEJMo

  10. 📊 In the NEJM STEP 9 trial, 407 adults with obesity and knee osteoarthritis receiving once-weekly semaglutide lost 13.7% of body weight vs. 3.2% with placebo, with greater reductions in knee pain and improved physical function over 68 weeks. GI events led to discontinuation in 6.7%. nejm.org/doi/abs/10.1056/NEJMo

  11. 📊 In the NEJM STEP 9 trial, 407 adults with obesity and knee osteoarthritis receiving once-weekly semaglutide lost 13.7% of body weight vs. 3.2% with placebo, with greater reductions in knee pain and improved physical function over 68 weeks. GI events led to discontinuation in 6.7%. #Obesity #Osteoarthritis nejm.org/doi/abs/10.1056/NEJMo

  12. Samsung Proposes Offer to Acquire Swiss CDMO Specializing in Peptides

    Samsung Biologics CEO, John Rim, says the PolyPeptide acquisition reinforces the company’s long-term growth strategy by not only…
    #EuropeSays #Korea #KR #SamsungBiologics #bioprocessing #contractmanufacturing #diabetes #IndustryNews #news #obesity #peptides #Samsung
    europesays.com/korea/128407/

  13. europesays.com/ie/648257/ Ozempic does something unexpected to the brain’s hunger neurons #Éire #Health #IE #Ireland #Obesity;Nutrition;WorkplaceHealth;Pharmacology;LanguageAcquisition;NutritionResearch;InfantAndPreschoolLearning;Marijuana

  14. An essay summarizing studies showing bias against obese people by both laypeople and by doctors:

    nutritionfacts.org/blog/weight

    #Health #Obesity #HealthCare

  15. An essay summarizing studies showing bias against obese people by both laypeople and by doctors:

    nutritionfacts.org/blog/weight

    #Health #Obesity #HealthCare

  16. An essay summarizing studies showing bias against obese people by both laypeople and by doctors:

    nutritionfacts.org/blog/weight

    #Health #Obesity #HealthCare

  17. An essay summarizing studies showing bias against obese people by both laypeople and by doctors:

    nutritionfacts.org/blog/weight

    #Health #Obesity #HealthCare

  18. An essay summarizing studies showing bias against obese people by both laypeople and by doctors:

    nutritionfacts.org/blog/weight

    #Health #Obesity #HealthCare

  19. Enveda Moves Ahead To Address Post-GLP-1 Weight Loss Maintenance – insights.citeline.com

    Enveda Moves Ahead To Address Post-GLP-1 Weight Loss Maintenance  insights.citeline.comA pill that mimics exercise? Early results on drug designed…
    #NewsBeep #News #Medication #ClinicalTrials #Health #Metabolicdisorders #Obesity #Research&Development #UK #UnitedKingdom
    newsbeep.com/uk/743647/

  20. An ‘Exercise Pill’ Just Cleared Its First Human Test

    Scientists might be inching closer to a breakthrough that some of us lazy bums would very much appreciate:…
    #NewsBeep #News #Health #exercise #experimentalresearch #GB #Obesity #UK #UnitedKingdom
    newsbeep.com/uk/743481/

  21. An ‘Exercise Pill’ Just Cleared Its First Human Test

    Scientists might be inching closer to a breakthrough that some of us lazy bums would very much appreciate:…
    #NewsBeep #News #Fitness #AU #Australia #Exercise #experimentalresearch #Health #Obesity
    newsbeep.com/au/861352/

  22. An ‘Exercise Pill’ Just Cleared Its First Human Test

    Scientists might be inching closer to a breakthrough that some of us lazy bums would very much appreciate:…
    #NewsBeep #News #Fitness #AU #Australia #Exercise #experimentalresearch #Health #Obesity
    newsbeep.com/au/861352/

  23. An ‘Exercise Pill’ Just Cleared Its First Human Test

    Scientists might be inching closer to a breakthrough that some of us lazy bums would very much appreciate:…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Fitness #exercise #experimentalresearch #Health #Obesity
    newsbeep.com/us/819241/

  24. Amylyx endocrine drug succeeds in key study for low blood sugar

    Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #biotechnology #drugdevelopment #Health #Obesity #Research #STAT+
    newsbeep.com/us/817717/

  25. Amylyx endocrine drug succeeds in key study for low blood sugar

    Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
    #NewsBeep #News #Medication #AU #Australia #Biotechnology #drugdevelopment #Health #Obesity #research #STAT+
    newsbeep.com/au/859679/

  26. Enveda weight loss maintenance pill mimics exercise in early tests

    If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
    #NewsBeep #News #Medication #AU #Australia #Biotech #CardiovascularDisease #chronicdiseases #drugdevelopment #Health #Obesity #Pharmaceuticals #STAT+
    newsbeep.com/au/859593/

  27. ‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs
    By Zoe Wood

    Users need discretionary income of nearly £100,000 a year to make savings on their grocery spend after paying £1,200 for GLP-1s, analysis finds

    theguardian.com/science/2026/a

    #Weightlossdrugs #Inequality #Science #Pharmaceuticalsindustry #Business #Health #Society #UKnews #Obesity #NHS #Privatehealthcare #TheGuardian #ZoeWood

  28. ‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs
    By Zoe Wood

    Users need discretionary income of nearly £100,000 a year to make savings on their grocery spend after paying £1,200 for GLP-1s, analysis finds

    theguardian.com/science/2026/a

    #Weightlossdrugs #Inequality #Science #Pharmaceuticalsindustry #Business #Health #Society #UKnews #Obesity #NHS #Privatehealthcare #TheGuardian #ZoeWood

  29. ‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs
    By Zoe Wood

    Users need discretionary income of nearly £100,000 a year to make savings on their grocery spend after paying £1,200 for GLP-1s, analysis finds

    theguardian.com/science/2026/a

    #Weightlossdrugs #Inequality #Science #Pharmaceuticalsindustry #Business #Health #Society #UKnews #Obesity #NHS #Privatehealthcare #TheGuardian #ZoeWood